AIM ImmunoTech Inc. (AIM) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
If you own shares in AIM ImmunoTech Inc. (NYSEMKT:AIM) then it's worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure of volatility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback